Companies

Companies
Company details

Phoenux AG

Phoenux AG is focused on research & building IP in the CNS sector. Phoenux specializes on molecules based on opioids targeted at addiction & the psychiatric disease of Borderline Personality Disorder

The company in detail

All
Reports

Related Reports

Market Research Reports provided by reports.iptechex.com

Contact details

To view this information, you must subscribe to Pharmalicensing Intelligence.

Head office

Phoenux AG
Chaltenbodenstr. 16
Schindellegi
CH 8834
Switzerland

Contact head office

Related companies

University of Arkansas for Medical Sciences

Inven2 AS

Leiras Takeda Pharmaceuticals

APR Applied Pharma Research S.A.

Alliance Pharmaceuticals (UK)

Related categories

Industry sector: Pharmaceutical; Pharmaceutical / Prescription
Therapeutic target: Central Nervous System; Central Nervous System / CNS (other); Central Nervous System / Psychiatric; Central Nervous System / Psychiatric / Mental health (other); Central Nervous System / Psychiatric / Opioid dependency

Clients in focus...

Get the Flash Player to see this rotator.

Products:	Partnering Search	Company Profiling	Pharmalicensing Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Industrial Sector	Therapeutic Target	Articles date
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	FAQ	Contact us	Site map